Cat.#: ACPP-1821
| Despition | NT 4 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 97.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1276 | MAP3K4 Blocking Peptide (AC1276) | 250 µg | inquiry |
| ACPP-1081 | Human NRN1 Protein (AC1081) | 5 µg | inquiry |
| ACPP-1302 | Noelin Blocking Peptide (AC1302) | 250 µg | inquiry |
| ACPP-1442 | Human TBCB Protein (AC1442) | 5 µg | inquiry |
| ACPP-1753 | Human SPR Protein (AC1753) | 5 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1177 | Recombinant Human Prostate Specific Antigen Protein (6×His Tag) (AC1177) | 50 µg | inquiry |
| ACPP-1555 | Human TGFBI Protein, 182 a.a. (AC1555) | 10 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1272 | Bestrophin Blocking Peptide (AC1272) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.